Case Reports

Hyperprogression to camrelizumab in a patient with esophageal squamous cell carcinoma harboring EGFR kinase domain duplication
Wei Wang, Meihong Wu, Minglu Liu, Zhengqing Yan, Guoqiang Wang, Dongliang Mao, Mei Wang

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000793; DOI: 10.1136/jitc-2020-000793
Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
Kartik Sehgal, Andreas Varkaris, Hollis Viray, Paul A VanderLaan, Deepa Rangachari, Daniel B Costa

Journal for ImmunoTherapy of Cancer Jun 2020, 8 (1) e000697; DOI: 10.1136/jitc-2020-000697
Exceptional response and multisystem autoimmune-like toxicities associated with the same T cell clone in a patient with uveal melanoma treated with immune checkpoint inhibitors
Suthee Rapisuwon, Benjamin Izar, Cory Batenchuk, Alexandre Avila, Shaolin Mei, Peter Sorger, Jerry M. Parks, Connor J. Cooper, David Wagner, Jay C. Zeck, Aline J. Charabaty, Michael B. Atkins

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 61; DOI: 10.1186/s40425-019-0533-0
Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report
Masood Sadaat, Sekwon Jang

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 49; DOI: 10.1186/s40425-018-0365-3
Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment
Léa Paolini, Caroline Poli, Simon Blanchard, Thierry Urban, Anne Croué, Marie-Christine Rousselet, Sarah Le Roux, Nathalie Labarrière, Pascale Jeannin, José Hureaux

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 52; DOI: 10.1186/s40425-018-0372-4
Rhabdomyolysis during high dose interleukin-2 treatment of metastatic melanoma after sequential immunotherapies: a case report
Joseph I. Clark, Shams Bufalino, Shruti Singh, Ewa Borys

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 53; DOI: 10.1186/s40425-018-0370-6
Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
Evidio Domingo-Musibay, Paari Murugan, Alessio Giubellino, Sandeep Sharma, Daniel Steinberger, Jianling Yuan, Matthew A. Hunt, Emil Lou, Jeffrey S. Miller

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 58; DOI: 10.1186/s40425-018-0357-3
Complete response to ipilimumab and nivolumab therapy in a patient with extensive extrapulmonary high-grade small cell carcinoma of the pancreas and HIV infection
Muhammad Husnain, Wungki Park, Juan Carlos Ramos, Thomas E. Johnson, Joseph Chan, Arvind Dasari, Raja Mudad, Peter J. Hosein

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 66; DOI: 10.1186/s40425-018-0379-x
Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab
Andrew Hantel, Brooke Gabster, Jason X. Cheng, Harvey Golomb, Thomas F. Gajewski

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 73; DOI: 10.1186/s40425-018-0384-0
Sick sinus syndrome associated with anti-programmed cell death-1
Chien-Yi Hsu, Yu-Wen Su, San-Chi Chen

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 72; DOI: 10.1186/s40425-018-0388-9

Main menu

Case Reports

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Case Reports

Pages